Trial Profile
The Effect of Formula Fortified With Docosahexaenoic Acid (DHA) on Infants With Cystic Fibrosis (CF)
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Docosahexaenoic acid (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- 15 May 2014 New trial record